Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an announcement.
China Isotope & Radiation Corporation announced a strategic cooperation agreement with Qianlong International Holdings Limited to advance the application of boron neutron capture therapy technology and other nuclear medicine solutions. This collaboration aims to enhance public health through technological innovation and strengthen the high-end nuclear medicine industry in both domestic and international markets.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear medicine industry, focusing on the development and application of nuclear medical equipment, radiopharmaceuticals, and intelligent nuclear medicine solutions.
Average Trading Volume: 407,723
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.73B
For an in-depth examination of 1763 stock, go to TipRanks’ Stock Analysis page.